NOC
41
9
AAPL
40
-6
AAL
57
-2
COP
57
-2
DRI
50
-3
GLW
45
-3
NWSA
62
-7
ROP
53
-9
TGNA
50
-6
TEL
60
-8
EOG
56
-2
ISRG
71
-5
PDCO
29
2
C
62
4
CVS
41
-4
COST
57
-6
PGR
59
-3
MU
28
-3
AON
54
2
TRIP
50
-4
NOC
41
9
AAPL
40
-6
AAL
57
-2
COP
57
-2
DRI
50
-3
GLW
45
-3
NWSA
62
-7
ROP
53
-9
TGNA
50
-6
TEL
60
-8
EOG
56
-2
ISRG
71
-5
PDCO
29
2
C
62
4
CVS
41
-4
COST
57
-6
PGR
59
-3
MU
28
-3
AON
54
2
TRIP
50
-4
Financhill
Back

Omega Therapeutics 10K Form

Sell
39

OMGA
Omega Therapeutics

Last Price:
0.77
Seasonality Move:
33.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OMGA News And Ratings

See the #1 stock for the next 7 days that we like better than OMGA

OMGA Financial Statistics

Sales & Book Value

Annual Sales: $3.09M
Cash Flow: $-13.07M
Price / Cash Flow: 0
Annual Sales: $0.48
Price / Book: 2.12

Profitability

EPS (TTM): -1.42000
Net Income (TTM): $-78.9M
Gross Margin: --
Return on Equity: -132.56%
Return on Assets: -39.33%

Omega Therapeutics Earnings Forecast

Key Omega Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,494.15% of Revenue.
  • The Interest Expense is -1.33% of Operating Income.
  • The Net Earning history of OMGA is -3,148.93% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Omega Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: OMGA
Website: omegatherapeutics.com

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 2.19
Quick Ratio: 1.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OMGA Technical Analysis vs Fundamental Analysis

Sell
39
Omega Therapeutics (OMGA) is a Sell

Is Omega Therapeutics a Buy or a Sell?